Survey of cancer screening practices and telehealth services among primary care physicians during the COVID-19 pandemic

Price, Sarah Tucker; Mainous, Arch G.; Rooks, Benjamin J.

doi:10.1016/j.pmedr.2022.101769

Cited by 10 publications

(13 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During the COVID-19 pandemic, the use of telemedicine has increased in many areas, such as outpatient care in general medical practices or follow-up care of surgery patients, often providing satisfactory results (Knörr et al 2022 ; Muschol et al 2022 ). Some cancer screenings have also been supported by telehealth services (Price et al 2022 ). One area that is particularly suitable for the use of telemedicine is dermatology (Trettel et al 2018 ).…”

Section: Discussionmentioning

confidence: 99%

COVID-19 related decline in cancer screenings most pronounced for elderly patients and women in Germany: a claims data analysis

Muschol

Strauss

Gissel

2022

J Cancer Res Clin Oncol

View full text Add to dashboard Cite

Purpose This study aimed to analyze the utilization of cancer screenings in Germany before and during the COVID-19 pandemic in 2020. The objective of the analysis was to identify the population at particular risk and to derive recommendations for the future use of resources to prevent long-term deteriorations in health outcomes. Methods The analysis was conducted based on claims data of all preventive health services for 15,833,662 patients from the largest statutory health insurance fund in Germany. Utilization of general female cancer screening, general male cancer screening, general health checkup, colorectal cancer screening stool test, colorectal cancer screening consultation, colonoscopy, skin cancer screening, and mammography screening was compared before (2017–2019) and during (2020) the pandemic. Results Data of a total of 42,046,078 observed screenings showed that the utilization of the individual screenings developed differently, but that the overall utilization decreased significantly by 21.46% during the COVID-19 pandemic (p < 0.001). At the same time, no catch-up effects were detected for total screenings throughout the entire year 2020. The highest decline in screenings was found for the elderly (p < 0.001) and women (p < 0.001). Conclusion Because the elderly are at higher risk for cancer, the omission of early detection might lead to higher treatment costs, reduced quality of life, and higher mortality. In addition, women's medical care in particular has been negatively affected, for example, by the interruption of mammography screenings and the lack of catch-up effects. Therefore, resources must be targeted to reduce burdens on health outcomes and public health in the long term.

show abstract

Section: Discussionmentioning

confidence: 99%

COVID-19 related decline in cancer screenings most pronounced for elderly patients and women in Germany: a claims data analysis

Muschol

Strauss

Gissel

2022

J Cancer Res Clin Oncol

View full text Add to dashboard Cite

show abstract

“…Oncologists in China also tried to implement active and effective measures for cancer care during the pandemic including establishing appointment schedule system, highly e cient COVID-19 screening procedure, and switch anti-cancer medication from infusion to oral [29]. In addition, primary care and family physician system, as well as remote online or telephone-based consultation could also help meet cancer patients' basic medical service needs during the pandemic [30,31].…”

Section: Discussionmentioning

confidence: 99%

Cancer Patients’ Health Related Quality of Life (HRQoL) and Its Predictor Factors during the COVID-19 Pandemic: A Cross-sectional Survey Study in China

Sun

Peng

Liu

et al. 2022

Preprint

View full text Add to dashboard Cite

Objective To evaluate Chinese cancer patients’ health related quality of life and its predictor factors during the COVID-19 pandemic. Method We conducted an online cross-sectional survey study among Chinese cancer patients in 2020 around China by utilizing the validated Mandarin version of COVID-19 IHRQOL questionnaire. Results 387 patients participated in this survey, in which 283(72.9%) patients worried the pandemic’s impact on their cancer care, 69% feared getting infected by COVID-19. 30.7% and 17.3% patients had experienced depression and social isolation. More than 80% patients reported perceived benefits such as feeling more grateful. 26.3% patients reported financial hardship and 44.9% reported cancer care disruption. Multivariate analyses showed that more financial hardship was significantly associated with higher level of COVID-19 specific distress (p < 0.001). Conclusion Addressing health care services disruption and financial hardship, as well as promoting functional social support might help Chinese cancer patients acquire better HRQoL during the pandemic.

show abstract

“…If these delays in cancer screening continue, it is estimated that more than 80,000 Americans will experience a delayed diagnosis of cancer [11]. Based on the delayed screenings in Spring of 2020 early in the pandemic, 10,000 excess deaths are expected to be attributed to breast and colorectal cancer over the next 10 years [12]. However, the impact on preventative screening can be mitigated.…”

Section: Figure 6: Monthly Trends In Cervical Cancer Screening Discus...mentioning

confidence: 99%

Evaluating the Impact of the COVID-19 Pandemic on Monthly Trends in Primary Care

Varandani¹,

Nagib²

2022

Cureus

View full text Add to dashboard Cite

As the COVID-19 pandemic progressed, multiple barriers arose for patients and providers in the primary care setting. Despite the attempt to utilize telemedicine to overcome barriers, visits remained lower than prepandemic levels. This raises concern for preventative medicine and chronic disease management. MethodsThis study aimed to evaluate the impact of the pandemic in primary care by utilizing two years of data from a family medicine clinic. Data obtained from the electronic medical record for March 2019 through February 2020 and March 2020 through February 2021 were used to evaluate monthly trends from the year before the pandemic and the first year of the pandemic in the following six categories: hypertension control, diabetes control, lipid profile screening, breast cancer screening, colorectal cancer screening, and cervical cancer screening. ResultsThe paired t-tests found a significant difference in the averages between the two years for all categories except hypertension control. The results for chi-square demonstrated a significant difference in four months for cervical cancer screening, five months for hypertension control and colorectal cancer screening, nine months for diabetes control and lipid profile screening, and 10 months for breast cancer screening. ConclusionThese results show a profound impact of the pandemic on both preventative medicine and chronic disease management. This study had a large sample size but is not generalizable to the entire population. These results can help guide quality improvement measures going forward. However, further research is necessary to better understand the full extent of COVID-19's impact on primary care.

show abstract

Survey of cancer screening practices and telehealth services among primary care physicians during the COVID-19 pandemic

Cited by 10 publications

References 44 publications

COVID-19 related decline in cancer screenings most pronounced for elderly patients and women in Germany: a claims data analysis

COVID-19 related decline in cancer screenings most pronounced for elderly patients and women in Germany: a claims data analysis

Cancer Patients’ Health Related Quality of Life (HRQoL) and Its Predictor Factors during the COVID-19 Pandemic: A Cross-sectional Survey Study in China

Evaluating the Impact of the COVID-19 Pandemic on Monthly Trends in Primary Care

Contact Info

Product

Resources

About